UP AFTER EARNINGS: Nu Skin (NUS) up 10.6%… Tandem Diabetes (TNDM) up 7.6%… Evolus (EOLS) up 5.4%… Acadia Healthcare (ACHC) up 3.1%… Teladoc (TDOC) up 2.5%… Vertex Pharma (VRTX) up 1.7%. ALSO HIGHER: ArQule (ARQL) up 5.5% after announcing China approval of derazantinib’s clinical trial application. DOWN AFTER EARNINGS: Healthcare Services (HCSG) down 20.2%… Exact Sciences (EXAS) down 1.9%… Amgen (AMGN) down 0.5%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.